Nitrofurantoin Orbit Pharma

Active Ingredient:: Nitrofurantoin
Origin:: EU

Nitrofurantoin Orbit Pharma (Nitrofurantoin)

Q: What is Nitrofurantoin Orbit Pharma used for?

Nitrofurantoin Orbit Pharma is an oral nitrofuran antibiotic indicated for the treatment of uncomplicated urinary tract infections caused by susceptible bacteria. It is also employed as a prophylactic agent to reduce the recurrence of urinary infections in patients with a history of repeated episodes.

Q: How does nitrofurantoin work?

Nitrofurantoin is reduced inside bacterial cells to reactive metabolites that damage DNA, ribosomal proteins, and enzymes involved in carbohydrate metabolism. This multi‑target disruption impairs cell wall synthesis and essential metabolic pathways, leading to rapid bactericidal activity against common urinary pathogens.

Q: What is the usual dose of Nitrofurantoin Orbit Pharma?

The specific dose and duration are determined by the prescribing clinician based on the infection severity, patient renal function, and local guidelines. Healthcare professionals should follow the recommended dosing regimen on the prescription label.

Q: Is Nitrofurantoin safe during pregnancy or breastfeeding?

Nitrofurantoin is classified as pregnancy category B, indicating no evidence of risk in animal studies and insufficient human data. It may be used during pregnancy when clearly needed, but it is generally avoided near term. Breastfeeding is permissible, though monitoring the infant for gastrointestinal upset is advisable.

Q: How do I order Nitrofurantoin Orbit Pharma from GNH India?

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Q: How does Nitrofurantoin compare with other urinary antibiotics?

Compared with agents such as trimethoprim‑sulfamethoxazole or fluoroquinolones, nitrofurantoin offers a narrow spectrum focused on common urinary pathogens and has a low propensity for promoting resistance. However, it requires adequate renal function for efficacy and may have a higher incidence of gastrointestinal side effects.

Q: What are the storage and handling requirements for Nitrofurantoin Orbit Pharma?

Store the product at ambient temperature below 25 °C, in its original packaging, and protect it from moisture. Keep the tablets away from direct sunlight and out of reach of children.

Q: How is Nitrofurantoin Orbit Pharma administered?

The medication is taken orally, usually with food or a full glass of water to minimise gastrointestinal irritation. Patients should swallow the tablets whole and follow the dosing schedule prescribed by their healthcare provider.

Q: What are the most serious risks associated with Nitrofurantoin?

Serious adverse events include pulmonary toxicity (interstitial pneumonitis or fibrosis), hepatic injury, hemolytic anemia in individuals with G6PD deficiency, and severe allergic reactions such as anaphylaxis. Prompt medical attention is required if any of these symptoms develop.

Q: Who should not use Nitrofurantoin Orbit Pharma?

Nitrofurantoin is contraindicated in patients with severe renal impairment (creatinine clearance <60 mL/min), known hypersensitivity to nitrofurantoin, or G6PD deficiency. Caution is also advised for patients with a history of pulmonary disease or liver dysfunction.

Nitrofurantoin, the active ingredient in Nitrofurantoin Orbit Pharma, is a nitrofuran antibiotic presented as an oral dosage form for oral use. It treats uncomplicated urinary tract infections in adult patients by targeting common urinary pathogens.
GNH India supplies Nitrofurantoin Orbit Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orbit Pharmalimited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nitrofurantoin is used to manage infections of the urinary tract and related prophylaxis.

Uncomplicated urinary tract infection: eradicates susceptible uropathogens and relieves typical symptoms such as dysuria and frequency.
Acute cystitis: provides rapid bactericidal activity to clear infection in the bladder.
Recurrent urinary tract infection prophylaxis: reduces the frequency of future episodes when used as a preventive regimen.

How It Works

Nitrofurantoin is reduced by bacterial flavoproteins to reactive intermediates that damage bacterial DNA, ribosomal proteins, and enzymes involved in carbohydrate metabolism. This multi‑target inhibition interferes with cell wall synthesis and essential metabolic pathways, resulting in bactericidal activity against common urinary pathogens such as Escherichia coli and Staphylococcus saprophyticus.

Side Effects

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects

Nausea: mild to moderate stomach upset.
Loss of appetite: reduced desire to eat.
Headache: transient cranial discomfort.
Diarrhoea: loose stools, usually self‑limiting.

Serious or Rare Side Effects

Pulmonary toxicity: interstitial lung disease or acute pneumonitis.
Hepatic injury: elevated liver enzymes or hepatitis.
Hemolytic anemia in G6PD deficiency: rapid destruction of red blood cells.
Severe allergic reactions: rash, angioedema, or anaphylaxis.

Precautions & Warnings

Nitrofurantoin requires careful assessment of patient factors and monitoring for adverse events.

Renal function assessment: avoid use in patients with creatinine clearance <60 mL/min.
G6PD deficiency: contraindicated due to risk of hemolysis.
Pulmonary monitoring: discontinue if cough, dyspnoea, or fever develop.
Duration limitation: limit therapy to the shortest effective course to reduce toxicity risk.
Pregnancy and lactation: category B, use only if clearly needed.
Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Nitrofurantoin may interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

Antacids containing magnesium or aluminium: reduce absorption of nitrofurantoin.
Probenecid: increases serum concentrations, raising toxicity risk.
Warfarin: may enhance anticoagulant effect, requiring INR monitoring.
Methenamine: concurrent use can diminish antibacterial activity.

Moderate Interactions (Monitor Closely)

Diuretics: increase risk of crystalluria, especially in dehydrated patients.
NSAIDs: potential additive renal impairment.
High‑dose Vitamin C: acidifies urine and may affect drug stability.
Ciprofloxacin: possible antagonistic effect on bacterial killing.

Frequently Asked Questions

Nitrofurantoin Orbit Pharma is an oral nitrofuran antibiotic indicated for the treatment of uncomplicated urinary tract infections caused by susceptible bacteria. It is also employed as a prophylactic agent to reduce the recurrence of urinary infections in patients with a history of repeated episodes.

Nitrofurantoin is reduced inside bacterial cells to reactive metabolites that damage DNA, ribosomal proteins, and enzymes involved in carbohydrate metabolism. This multi‑target disruption impairs cell wall synthesis and essential metabolic pathways, leading to rapid bactericidal activity against common urinary pathogens.

The specific dose and duration are determined by the prescribing clinician based on the infection severity, patient renal function, and local guidelines. Healthcare professionals should follow the recommended dosing regimen on the prescription label.

Nitrofurantoin is classified as pregnancy category B, indicating no evidence of risk in animal studies and insufficient human data. It may be used during pregnancy when clearly needed, but it is generally avoided near term. Breastfeeding is permissible, though monitoring the infant for gastrointestinal upset is advisable.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with agents such as trimethoprim‑sulfamethoxazole or fluoroquinolones, nitrofurantoin offers a narrow spectrum focused on common urinary pathogens and has a low propensity for promoting resistance. However, it requires adequate renal function for efficacy and may have a higher incidence of gastrointestinal side effects.

Store the product at ambient temperature below 25 °C, in its original packaging, and protect it from moisture. Keep the tablets away from direct sunlight and out of reach of children.

The medication is taken orally, usually with food or a full glass of water to minimise gastrointestinal irritation. Patients should swallow the tablets whole and follow the dosing schedule prescribed by their healthcare provider.

Serious adverse events include pulmonary toxicity (interstitial pneumonitis or fibrosis), hepatic injury, hemolytic anemia in individuals with G6PD deficiency, and severe allergic reactions such as anaphylaxis. Prompt medical attention is required if any of these symptoms develop.

Nitrofurantoin is contraindicated in patients with severe renal impairment (creatinine clearance <60 mL/min), known hypersensitivity to nitrofurantoin, or G6PD deficiency. Caution is also advised for patients with a history of pulmonary disease or liver dysfunction.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 27 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.